• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种植体周围口腔鳞状细胞癌(OSCC):临床病理特征与分期问题

Peri-Implant Oral Squamous Cell Carcinoma (OSCC): Clinicopathological Features and Staging Issues.

作者信息

Limongelli Luisa, Dell'Olio Fabio, D'Amati Antonio, Cascardi Eliano, Forte Marta, Siciliani Rosaria Arianna, Manfuso Alfonso, Maiorano Eugenio, Favia Gianfranco, Copelli Chiara, Capodiferro Saverio

机构信息

Odontostomatology Unit, Interdisciplinary Department of Medicine, Aldo Moro University of Bari, 70125 Bari, Italy.

Pathology Unit, Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari "Aldo Moro", 70124 Bari, Italy.

出版信息

Cancers (Basel). 2025 Jun 26;17(13):2149. doi: 10.3390/cancers17132149.

DOI:10.3390/cancers17132149
PMID:40647448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12248644/
Abstract

Eighty-five percent of peri-implant malignancies are oral squamous cell carcinomas (OSCCs), and most of them are misdiagnosed as peri-implantitis because of their clinical and radiological presentation; few studies have focused on addressing and solving the diagnostic issues related to peri-implant OSCCs. The study aimed to describe the clinicopathological features of peri-implant OSCCs and to report the staging issues related to the diagnosis of these lesions. This retrospective cohort study included patients who received a diagnosis of and treatment for peri-implant OSCCs at the Unit of Dentistry of the "Aldo Moro" University of Bari (Italy) from 2018 to 2024. By using descriptive statistics, the authors highlighted the diagnostic issues related to the clinical presentation, radiological features, and histology of peri-implant OSCCs. A total of 13 women and 8 men with a mean age of 70.6 ± 11.7 years met the inclusion criteria; the medical history of the participants showed potentially malignant disorders (OPMDs) in 52.4% of patients, whereas 14.3% had already developed an OSCC. The patients showed 24 peri-implant OSCCs; the clinical presentation was leuko-erythroplakia-like (41.7%) or erythroplakia-like (58.3%), thus simulating peri-implantitis; in addition, 52.0% of dental implants involved had a probing pocket depth ≥ 10 mm, further mimicking peri-implantitis. Panoramic radiograms and cone beam computed tomography were of little use in studying bundle bone-implant interfaces; in particular, the tomography showed circumferential bone resorption only in peri-implantitis-like OSCCs. In total, 91.6% of histological examinations of OSCCs showed peri-implantitis-like inflammation; early-stage lesions (pTNM I-II) accounted for 33.3%, whereas late-stage lesions (pTNM III-IV) accounted for 66.7%; lymph nodal metastases occurred in 25.0% and 62.5%, respectively. The mean follow-up was 3.4 ± 1.0 years; all patients with OPMDs had poorly differentiated tumors and thus showed a worse prognosis than those without OPMDs (mean disease-free survival of 15.5 ± 7.7 months and 44.7 ± 12.1 months, respectively). The results of the study showed that peri-implant OSCCs occurred most frequently in patients with OPMDs or previous OSCC; in addition, peri-implant OSCCs required demolition rather than conservative excision, and the prognosis of patients strictly depended on the grade of the cancer. In the authors' experience, the clinical-radiological presentation simulating peri-implantitis was the feature that concurred most in complicating the diagnosis of those tumors.

摘要

85%的种植体周围恶性肿瘤为口腔鳞状细胞癌(OSCC),由于其临床和影像学表现,其中大多数被误诊为种植体周围炎;很少有研究致力于解决与种植体周围OSCC相关的诊断问题。本研究旨在描述种植体周围OSCC的临床病理特征,并报告与这些病变诊断相关的分期问题。这项回顾性队列研究纳入了2018年至2024年在意大利巴里“阿尔多·莫罗”大学牙科学院接受种植体周围OSCC诊断和治疗的患者。通过描述性统计,作者强调了与种植体周围OSCC的临床表现、影像学特征和组织学相关的诊断问题。共有13名女性和8名男性符合纳入标准,平均年龄为70.6±11.7岁;参与者的病史显示,52.4%的患者有潜在恶性疾病(OPMD),而14.3%的患者已经发生了OSCC。患者共出现24例种植体周围OSCC;临床表现为白斑样(41.7%)或红斑样(58.3%),从而模拟种植体周围炎;此外,52.0%的受累牙种植体探诊袋深度≥10 mm,进一步模拟种植体周围炎。全景X线片和锥形束计算机断层扫描在研究束状骨-种植体界面方面作用不大;特别是,断层扫描仅在种植体周围炎样OSCC中显示圆周骨吸收。总的来说,91.6%的OSCC组织学检查显示种植体周围炎样炎症;早期病变(pTNM I-II)占33.3%,而晚期病变(pTNM III-IV)占66.7%;淋巴结转移分别发生在25.0%和62.5%的患者中。平均随访时间为3.4±1.0年;所有患有OPMD的患者肿瘤分化差,因此预后比没有OPMD的患者更差(无病生存期分别为15.5±7.7个月和44.7±12.1个月)。研究结果表明,种植体周围OSCC最常发生在患有OPMD或既往有OSCC的患者中;此外,种植体周围OSCC需要拆除而不是保守切除,患者的预后严格取决于癌症的分级。根据作者的经验,模拟种植体周围炎的临床-影像学表现是这些肿瘤诊断复杂化的最主要特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/30e81ea2e1cb/cancers-17-02149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/08763a9782ae/cancers-17-02149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/1327a29c4a15/cancers-17-02149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/aa1e27ccc727/cancers-17-02149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/30e81ea2e1cb/cancers-17-02149-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/08763a9782ae/cancers-17-02149-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/1327a29c4a15/cancers-17-02149-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/aa1e27ccc727/cancers-17-02149-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39f6/12248644/30e81ea2e1cb/cancers-17-02149-g002.jpg

相似文献

1
Peri-Implant Oral Squamous Cell Carcinoma (OSCC): Clinicopathological Features and Staging Issues.种植体周围口腔鳞状细胞癌(OSCC):临床病理特征与分期问题
Cancers (Basel). 2025 Jun 26;17(13):2149. doi: 10.3390/cancers17132149.
2
Interventions for replacing missing teeth: treatment of peri-implantitis.缺失牙修复干预措施:种植体周围炎的治疗
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD004970. doi: 10.1002/14651858.CD004970.pub5.
3
Adjunctive antimicrobial photodynamic therapy for treating periodontal and peri-implant diseases.辅助抗菌光动力疗法治疗牙周病和种植体周围病。
Cochrane Database Syst Rev. 2024 Jul 12;7(7):CD011778. doi: 10.1002/14651858.CD011778.pub2.
4
Treatment of peri-implantitis: what interventions are effective? A Cochrane systematic review.种植体周围炎的治疗:哪些干预措施有效?一项Cochrane系统评价
Eur J Oral Implantol. 2012;5 Suppl:S21-41.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.
8
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Malignancy around implants in patients with a history of a potentially malignant or malignant lesion: a systematic review.有潜在恶性或恶性病变病史的患者的植入物周围恶性肿瘤:系统评价。
Gen Dent. 2024 May-Jun;72(3):34-40.
2
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.西米普利单抗治疗局部晚期或转移性皮肤鳞状细胞癌:来自药物获取协议的前瞻性真实世界数据。
Lancet Reg Health Eur. 2024 Mar 5;39:100875. doi: 10.1016/j.lanepe.2024.100875. eCollection 2024 Apr.
3
Clinical retrospective analysis of peri-implant oral malignancies.
种植体周围口腔恶性肿瘤的临床回顾性分析。
Int J Implant Dent. 2024 Feb 6;10(1):5. doi: 10.1186/s40729-024-00527-0.
4
Inflammatory Gene Profile and Particle Presence in Peri-Implant Mucosa: a Pilot Study on 9 Patients.种植体周围黏膜中的炎症基因谱与颗粒存在情况:一项针对9例患者的初步研究
J Oral Maxillofac Res. 2023 Sep 30;14(3):e2. doi: 10.5037/jomr.2023.14302. eCollection 2023 Jul-Sep.
5
Differentiating Post-treatment Changes from Tumor Recurrence in the Oral Cavity and Oropharynx.区分口腔和口咽治疗后变化与肿瘤复发
Semin Roentgenol. 2023 Jul;58(3):272-289. doi: 10.1053/j.ro.2023.04.001. Epub 2023 May 6.
6
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
7
Do dental implants facilitate bone invasion in patients with oral squamous cell carcinoma? A case series.牙种植体是否会促进口腔鳞状细胞癌患者的骨侵犯?一项病例系列研究。
Int J Oral Maxillofac Surg. 2023 Apr;52(4):413-416. doi: 10.1016/j.ijom.2022.08.004. Epub 2022 Aug 22.
8
PD-L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside.口腔鳞状细胞癌中的 PD-L1:从实验室到 bedside 的关键生物标志物。
Clin Exp Dent Res. 2022 Jun;8(3):690-698. doi: 10.1002/cre2.590. Epub 2022 May 20.
9
Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Tumours of the Oral Cavity and Mobile Tongue.从世界卫生组织第五版头颈部肿瘤分类更新:口腔和活动舌肿瘤。
Head Neck Pathol. 2022 Mar;16(1):54-62. doi: 10.1007/s12105-021-01402-9. Epub 2022 Mar 21.
10
Squamous cell carcinoma around a subperiosteal implant in the maxilla and the association of chronic mechanical irritation and peri-implantitis: a case report.上颌骨骨膜下种植体周围的鳞状细胞癌及慢性机械刺激与种植体周围炎的关系:一例报告。
Int J Implant Dent. 2022 Mar 2;8(1):10. doi: 10.1186/s40729-022-00409-3.